Insider · CIK 0001369453

Wentworth Kerry

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001369453

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	NUVBNuvation Bio Inc.M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	+63K sh	$2.93	+$185K	116,000
2026-06-23	NUVBNuvation Bio Inc.S Sale	CHIEF REGULATORY OFFICER	SSale	−63K sh	$6.02	−$379K	53,000
2026-06-23	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	−63K sh	—	—	152,250
2026-04-17	NUVBNuvation Bio Inc.M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	+36.8K sh	$2.93	+$108K	89,750
2026-04-17	NUVBNuvation Bio Inc.S Sale	CHIEF REGULATORY OFFICER	SSale	−36.8K sh	$5.01	−$184K	53,000
2026-04-17	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	−36.8K sh	—	—	215,250
2026-04-06	NUVBNuvation Bio Inc.M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	+100K sh	$1.87	+$187K	153,000
2026-04-06	NUVBNuvation Bio Inc.M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	+100K sh	$1.94	+$194K	253,000
2026-04-06	NUVBNuvation Bio Inc.S Sale	CHIEF REGULATORY OFFICER	SSale	−200K sh	$4.52	−$904K	53,000
2026-04-06	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	−100K sh	—	—	400,000
2026-04-06	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF REGULATORY OFFICER	MExercise/Conversion	−100K sh	—	—	300,000
2026-02-27	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	CHIEF REGULATORY OFFICER	AAward	+748K sh	—	—	748,130
2025-06-16	NUVBNuvation Bio Inc.P Purchase	CHIEF REGULATORY OFFICER	PPurchase	+26K sh	$1.79	+$46.5K	26,000
2025-06-16	NUVBNuvation Bio Inc.P Purchase	CHIEF REGULATORY OFFICER	PPurchase	+24K sh	$1.80	+$43.2K	50,000
2025-02-28	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	CHIEF REGULATORY OFFICER	AAward	+500K sh	—	—	500,000
2024-02-29	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	CHIEF REGULATORY OFFICER	AAward	+500K sh	—	—	500,000
2023-02-28	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	CHIEF REGULATORY OFFICER	AAward	+400K sh	—	—	400,000
2022-08-29	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	CHIEF REGULATORY OFFICER	AAward	+252K sh	—	—	252,000
2022-05-23	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	CHIEF REGULATORY OFFICER	AAward	+330K sh	—	—	330,000
2022-05-23	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	CHIEF REGULATORY OFFICER	AAward	+248K sh	—	—	247,500
2021-11-19	Flexion Therapeutics IncD Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−141K sh	$8.50	−$1.2M	0
2021-11-19	Flexion Therapeutics IncD Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−6,000 sh	$8.50	−$51K	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−24K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−10K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−10K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−20K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−35K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−33.3K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−18K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−15.5K sh	—	—	0
2021-11-19	Flexion Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−20K sh	—	—	0
2021-07-19	Flexion Therapeutics IncS Sale	Chief Regulatory Officer	SSale	−3,944 sh	$6.45	−$25.4K	140,362
2021-06-21	Flexion Therapeutics IncA Award	Chief Regulatory Officer	AAward	+539 sh	$7.78	+$4,193.42	144,306
2021-03-01	Flexion Therapeutics IncA Award	Chief Regulatory Officer	AAward	+30K sh	—	—	143,767
2021-03-01	Flexion Therapeutics IncStock option (right to buy)A Award	Chief Regulatory Officer	AAward	+20K sh	—	—	20,000
2021-01-05	Flexion Therapeutics IncS Sale	Chief Regulatory Officer	SSale	−6,829 sh	$11.13	−$76K	113,767
2020-07-16	Flexion Therapeutics IncA Award	Chief Regulatory Officer	AAward	+38.8K sh	—	—	120,180
2020-06-22	Flexion Therapeutics IncA Award	Chief Regulatory Officer	AAward	+369 sh	$10.83	+$3,996.27	81,430
2020-03-02	Flexion Therapeutics IncA Award	Chief Regulatory Officer	AAward	+31K sh	—	—	81,061
2020-03-02	Flexion Therapeutics IncStock option (right to buy)A Award	Chief Regulatory Officer	AAward	+15.5K sh	—	—	15,500
2020-01-03	Flexion Therapeutics IncS Sale	Chief Regulatory Officer	SSale	−3,724 sh	—	—	50,061
2019-10-07	Flexion Therapeutics IncF Tax Payment	Chief Regulatory Officer	FTax Payment	−1,002 sh	$13.98	−$14K	53,394
2019-10-06	Flexion Therapeutics IncM Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+3,400 sh	—	—	54,396
2019-10-06	Flexion Therapeutics IncRestricted Stock Unit AwardM Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−3,400 sh	—	—	0
2019-06-21	Flexion Therapeutics IncA Award	Chief Regulatory Officer	AAward	+389 sh	$9.81	+$3,816.09	50,996
2019-03-01	Flexion Therapeutics IncA Award	Chief Regulatory Officer	AAward	+36K sh	—	—	50,607
2019-03-01	Flexion Therapeutics IncStock option (right to buy)A Award	Chief Regulatory Officer	AAward	+18K sh	—	—	18,000
2019-01-03	Flexion Therapeutics IncS Sale	Chief Regulatory Officer	SSale	−622 sh	$12.36	−$7,687.92	11,207
2018-10-08	Flexion Therapeutics IncF Tax Payment	Chief Regulatory Officer	FTax Payment	−1,002 sh	$18.60	−$18.6K	14,876
2018-10-08	Flexion Therapeutics IncF Tax Payment	Chief Regulatory Officer	FTax Payment	−1,002 sh	$18.60	−$18.6K	11,476

Recent filings

Accepted (ET)
Jun 244
Wentworth Kerry0001369453-26-000008
SEC(opens sec.gov)
Apr 214
Wentworth Kerry0001369453-26-000006
SEC(opens sec.gov)
Apr 84
Wentworth Kerry0001369453-26-000005
SEC(opens sec.gov)
Mar 34
Wentworth Kerry0001369453-26-000003
SEC(opens sec.gov)
Jun 184
Wentworth Kerry0001415889-25-017657
SEC(opens sec.gov)
Mar 44
Wentworth Kerry0001415889-25-006705
SEC(opens sec.gov)
Mar 44
Wentworth Kerry0001415889-24-006313
SEC(opens sec.gov)
Mar 24
Wentworth Kerry0001209191-23-014884
SEC(opens sec.gov)
Aug 314
Wentworth Kerry0001209191-22-048156
SEC(opens sec.gov)
May 254
Wentworth Kerry0001209191-22-031879
SEC(opens sec.gov)

Companies

Address

C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401

NEW YORK, NY, 10036